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Abstract
Background: Patients with ≥ 3 recurrent spontaneous miscarriages are classified as having RSM. Polycystic ovary
syndrome (PCOS) is associated with insulin resistance (IR). The purpose of this study is to evaluate the association
of IR and RMS.
Methods: Present case- control prospective study was performed on 100 women in control group (with a history
of at a live birth and no history of one more abortion) and study group (with a history of ≥ 3 RMS) who were not
diabetes and PCOS. Two groups matched in base of age and body mass index. Blood was withdrawn from the
case and control patients for the determination of the fasting blood glucose (FG), fasting insulin (FI) levels and
ultrasonography was performed on all the patients.
Results: The observed differences between age, FG and FG to FI ratio levels in case and control groups were not
significant (p > 0.05) but it was significant about fasting insulin (p = 0.0119). FI of < 20 μu/ml or ≥ 20 μu/ml in case
and control group was significant (Chi-square: 4.083, p: 0.0433, odds ratio: 4.4386, CI95% = 1.1541 to 17.0701),
whereas the difference between absolute and proportional frequency of patients with FG to FI ratio of < 4.5 and ≥
4.5 in case and control groups was not significant (Chi-square: 2.374, p = 0.123).
Conclusion: Current study showed that in women with RPL, in Iranian race like Americans, frequency of insulin
resistance in high, therefore there is a probability of the degree of insulin resistance in women with RPL.
Background
Recurrent pregnancy loss (RPL) is estimated to occur in
2%-4% of reproductive -age couples [1]. Patients with ≥
3 recurrent spontaneous miscarriages are classified as
having RSM. An RSM remains is a very disturbing event
to the affected patients by this health problem; they are
always anxious to find the underlying reasons for their
miscarriages. This is also a major challenge to the treat-
ing physicians [2]. It is a major hazard in pregnancy,
both for naturally conceived and those after assisted
reproductive technology (ART) treatment [3].
Intensive researches including immunological and
genetic studies are still in progress to illustrate the
cause of RSM [2]. Chromosome anomaly, uterine mal-
formations or anomalies, hypothyroidism, cervical in
competence, anti phospholipid syndrome, bacterial
infections and polycystic ovary syndrome (PCOS) are
some of the etiological factors associated with RSM [4],
[5]. There are some reports of high RSM rates in over
weight/obese infertile women treated by ART [6].
Other reports are the condition of PCOS which is
probably linked with obesity [7]; this may be due to the
high prevalence of overweight/obesity in PCOS women
[8]. PCOS is associated with insulin resistance (IR)inde-
pendent of total or fat- free body mass which can be a
key factor behind the link between PCOS/obesity and
the risk of spontaneous abortion [3,9]. IR is often
increased in 40% women with PCOS [4],[10], and hyper-
insulinemia is an etiological factor in the pathogenesis of
PCOS [11]. Further studies detected a correlation
between increasing insulin resistance and fasting insulin
level, with PRL [12]. The exact mechanism of how IR
leads to RSM is unknown [2]. IR can be diagnosed by
the determination of the fasting glucose to fasting
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[13]. In the present study we were tried to evaluate the
association of IR and recurrent pregnancy loss in our
area.
Methods
The present case- control prospective study evaluated
between March 2007 and March 2008 in the Depart-
ment of Obstetrics and Gynecology, Shahid Yahyanejad
Hospital, in Iran. At the first 114, patients were evalu-
ated, however, 7women from the study group and 7
women from control group were eliminated due to not
recon tact us.
Fifty non pregnant women with ≥ 2 RSM with history,
positive serum B-HCG and ultrasound documentation
of pregnancy, with same sex partner without history of
diabetes, were classified as case group. Pregnancy loss
was defined as any natural abortion occurring before 24
weeks gestation [1]. Fifty women in reproductive age,
non-diabetic, had at least one live birth and/or maxi-
mum of one were selected as the control group. The
patients of two groups matched in terms of age and
body mass index. For the case groups, they completed
an evaluation for RSM that included: hysterosalpingo-
gram, serum prolactin, TSH, midluteal serum P, lupus
anticoagulant, IgG, IgM, IgA anticardiolipin, antipho-
sphatidyl serine antibodies, karyotypes on both partners
and cervical cultures for Chlamydia, urea plasma,
mycoplasma.
Patients with the history of non - consecutive miscar-
riages, ectopic pregnancy, molar pregnancy, diabetes,
multiple partner, PCOS, and current pregnancy were
out of the study. The objective and design of this study
were explained to all the patients and whole data was
completely secret. A written informed consent was
obtained from all the participants. The Ethics Commit-
tee of the Babol Medical Science University approved
the study protocol.
The diagnosis of PCOS patients were based upon the
history of having chronic oligoamenorrhea (oligoame-
norrhea and amenorrhea were defined as ≤ 6m e n s e s
per year and no menses for 1 year retrospectively), clini-
cal and biochemical hyperanderogenism (hirsutism, and
severe acne and high levels of total or free testosterone,
and rostenedione and DHEAS), abnormal hormonal
tests of FSH, LH and those found on ultrasound to con-
tain 12 or more follicles measuring 2 to 9 mm in
diameter.
Blood was withdrawn from the case and control
patients for the determination of the fasting blood glu-
cose (FG) and fasting insulin (FI) levels. The patients
had 12-hour overnight fast before the blood was
extracted from the patients between 8:00 and 10:a.m. on
the day of the test [14]. Fasting serum insulin was
determined by a ECL method (Kit: Gbas, Hitachi 2010,
Japan). Glucose concentration was determined by the
glucose oxides method(Kit: Pars Azmon, Hitachi 2010,
Japan). The insulin resistance is diagnosed by the deter-
mination of the fasting glucose to fasting insulin ratio, a
ratio of < 4.5 or insulin level of ≥ 20 μunit being diag-
nostic of insulin resistance[12].
Statistical analysis
The complete data from the two groups were subjected
to statistical analysis using Chi-square for determination
of a variable between two groups and t-test for the com-
parison between two qualities using SPSS package.
Result
At first, 114 patients were evaluated but 7 women from
the case group and 7 women from the control group
were eliminated due to not recon tact us. Mean and
standard deviation of case group were 28.15 and ± 4.76,
respectively (between 19 and 41 years).
Based from the results taken from independent Sam-
ple t-test about comparison of the mean of age, fasting
blood glucose (FG), fasting insulin (FI) and FG to FI
ratio levels in case and control is shown in- Table 1-,
the observed differences between age, FG and FG to FI
ratio levels in case and control groups were not signifi-
cant (p > 0.05) but it was significant about fasting insu-
lin (p = 0.0119).
Based from the results taken from Chi-square about
the comparison of absolute and comparative frequency
of patients with FI of < 20 μu/ml or ≥ 20 μu/ml in case
and control group was significant (Chi-square:4.083, p:
0.0433, odds ratio: 4.4386, CI95% = 1.1541 to 17.0701),
whereas the difference between absolute and propor-
tional frequency of patients with FG to FI ratio of < 4.5
and ≥ 4.5 in case and control groups was not significant
Table 1 Comparison of the mean of age, fasting blood
glucose (FG), fasting insulin (FI) and FG to FI ratio levels
in case and control groups
Parameter Groups Frequency Mean SD ±
Mean
TP
value
Age Control 50 28/28 4/77 0/
568
0/5715
Case 50 28/02 4/57
FG Control 50 90/56 10/12 1/
810
0/0735
Case 50 94/12 9/34
FI Control 50 12/23 5/64 2/
565
0/0119
Case 50 15/20 5/82
FG to FI
ratio
Control 50 8/40 3/26 1/
726
0/0876
Case 50 7/26 3/28
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taken Chi-square test, the difference between absolute
and proportional frequency of patients with IR in case
and control groups was significant with (p: 0.0248,)
(Table 2).
The comparison of absolute and proportional fre-
quency of patients with BMI ≥ 27 and patients with
BMI < 27 and the difference between absolute and pro-
portional frequency of patients with IR in both groups
with P = 0.75 was not significant.
Discussion
Recurrent pregnancy loss (RPL) is estimated to occur in
2-4% of reproductive - age couples [1]. A multitude of
etiologic factors have been proposed, including: 3.1%
genetic (balanced translocations) 20.2% endocrinologic
(elevated levels of serum TSH. hyper prolactinemia,
luteal phase defects), 21.6% anatomic (congenital uterine
anomalies, Asherman’s syndrome, leionyomata, uterine-
Polyps or septa), 25% immunologic (elevated levels of
anticardiolipin or antiphospholipid antibodies, lupus
anticoagulant) and 5.8%. microbidogic factors [12,15].
Further studies detected a correlation between increas-
ing insulin resistance and fasting insulin level, with PRL.
These findings caused the investigation of IR in women
with other causes of PRL.Craig et al in their study
showed increased prevalence of insulin resistance in
women with a history of at least 2 pregnancy losses [12].
Present study was performed on 100 women incase
and control group (with a history of at least a live birth
and no history of one more abortion) and the study
group (with a history of ≥ 2 RPL) who were not diabetic
and PCOS. Mean and standard deviation of age were
28.18 ± 4.67 (at least 19 and maximum 41 years old). A
group of 21-25 years old with 28 patients (28%) was the
most frequent group. And in the age group of 26-30
years old with 26 patients (26%) also depending upon
our study, the average of the age height, weight and
BMI between case group and control group did not
have significant difference which was not unpredictable
based on matching control and case. According to Craig
et al results [12], also the frequency of patients with
high level of FI (FI ≥ 20 μu/ml)i nc a s eg r o u pw a ss i g -
nificantly more than the control group (22.45% versus
6.21%, odds Ratio 4.4386, CI: 95% = 1.1541 to 17.0701)
and frequency of patients with IR is significantly higher
than the frequency of these patients in control group
(22.49% versus 8.16%, odds Ratio 3.6486, CI 95% =
1.0855 to 12.2642), but no significant difference was
detected between the patients with proportion of FG to
FI ratio(G:I) less than 4.5 between case and control
group. These findings were in harmony with Craig et al.
findings. In Crag et al., study’s FI in case group was sig-
nificantly more than control group and the proportion
of patients with high FI and IR in case group was signif-
icantly more than control group [12].
In our study and Craig et al., study, also versus other
studies the patients with undefined spontaneous miscar-
riages were investigated, all the patients with RPL were
under survey [16,17]. May be because of this the most
patients has more than one reason for miscarriage
[12,15-18]. Consequently there is more probability for
presenting more than one cause of miscarriage in the
patient in which finding of one responsible cause stops
finding of other cause. Therefore in raft of studied
patients IR was not detected. Craig et al; study’ss h o w e d
in 11 patients of 38 patients with RPL (28.9%) there is
one more cause except insulin resistance for RPL [12].
Different concepts of insulin resistance may cause the
different results of this study and other studies. In cur-
rent study we used Craig et al procedure for insulin
resistance concept which means fasting insulin of ≥ 20
μu/ml and/or of fasting blood sugar to fasting insulin
ratio less than 45. Legro etal., concluded fasting G: I
(glucose/Insulin) ratio is maybe useful as a screening
test for insulin resistance in obese non-Hispanic white
PCOS women, with the highest sensitivity and specifi-
city. The exact mechanism of insulin resistance for RPL
is not completely clear but there is some explanation
about it [19].
It is possible that PCOS women have a hostile uterine
environmental milieu which causes decrease conception
and/or early miscarriages. Elevated PAI-I (plasminogen
activator inhibitor-I, an endogenous inhibitor of fibrino-
lysis) levels have been independently associated with
recurrent miscarriages in PCOS women [20].
Metformin enhances luteal phase uterine vascularity
and blood flow and reduce the rate of first trimester
spontaneous abortions [21,22]. Metformin therapy
throughout pregnancy in women with PCOS reduces
the otherwise high rate of first-trimester spontaneous
abortion [14]. Some in vitro data demonstrate that insu-
lin and glucose modulate glucose transporter at the cel-
lular level of the placentaltrophoblast. Thus maternal
Table 2 Comparison of absolute and comparative
frequency of patients with insulin resistance (IR) in case
and control groups
Groups IR Non-IR T
Control Absolute frequency 4 46 100
Proportional frequency %8 %92 %100
Case Absolute frequency 12 38 100
Proportional frequency %24 %76 %100
Total Absolute frequency 16 84 100
Proportional frequency %16 %84 %100
Chi-square = 5.038 P = 0.0248 Odds ratio = 3.6486
CI95% = 1.0855 to 12.2642
Maryam et al. BMC Research Notes 2012, 5:133
http://www.biomedcentral.com/1756-0500/5/133
Page 3 of 5insulin and glycemic status may influence the expression
of GLUTI [23], also some researchers showed the rule
of PA inhibitor which is elevated in women with RPL
[24,25]. Increases by elevation of insulin level and
decreases with insulin, sensitizator drugs [14,26]. Maybe
elevation of this component changes the trombotic pro-
cess and causes failure in placenta and at last loss of
pregnancy [12].
Conclusion
Current study showed that inw o m e nw i t hR P L ,i nI r a -
nian race like Americans, frequency of insulin resistance
in high, therefore there is a probability of the degree of
insulin resistance in women with RPL. We recommend
that glucose and fasting insulin levels in serum should
be measured in all women with RPL. Also another,
study in other similar studies in different population is
necessary to confirm these findings and the effect of
reluctant plasma glucose concentrations drugs in
women with history of RPL which should be evaluated
in further studies.
Present study involved in some limitation for example,
this study done just in one hospitals in Babol city and
doesn’t cover all hospitals. We suggest to future
researchers to cover big population.
Source of finding
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